Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Navigating the World of Retina: Updates for the Newer Retina Specialist

This course has expired. You can still review the content but course credit is no longer available.

In Person Credits: 1.5

Expiration Date: Friday, October 18, 2019
Release Date: October 12, 2019

Learning Objectives

  • Summarize the most recent clinical study evidence using available theraies for age-related macular edema (AMD)and diabetic macular edema (DME)..
  • Identify treatments under investigation for AMD and DME.
  • Develop individualized treatment plans for patients with retinal disorders that use a combination of imaging, treat and extend, or treat and observe approaches
  • Evaluate practice flow to determine the most efficient patient experience.
  • Establish and Implement plans to reduce reimbursement denials.

Accreditation and Designation Statement

  • Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • Evolve Medical Education LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation.

Faculty and Disclosures

DEAN ELIOTT, MD 
Director, Retina Service
Massachusetts Eye and Ear
Stelios Evangelos Gragoudas Professor Harvard Medical School
Boston, Massachusetts

SRINIVAS SADDA, MD 
Professor of Ophthalmology
Doheny Eye Institute, Department of Ophthalmology
David Geffen School of Medicine at UCLA
Los Angeles, California

Gaurav K. Shah, MD
Partner, The Retina Institute
St. Louis, Missouri

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

  • Dean Eliott, MD, and or spouse, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Alimera, Allergan, Dutch Ophthalmic, Genentech and Regenxbio, Grant Research Support: Neurotech. Stock/Shareholder: Aldeyra Therapeutics, and Pykus Therapeutics.
  • SriniVas Sadda, MD, and or spouse, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Amgen, Carl Zeiss Meditec, Centervue, Heidelberg, Nidek, Novartis, Optos, Roche/Genentech and 4DMT. Grant/Research Support: Carl Zeiss Meditec. Speaker’s Bureau: Bayer, CenterVue, Heidelberg, Nidek and Topcon. Research Instruments: Nidek and Topcon
  • Guarav K. Shah, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bausch & Lomb, DORC, Novartis, Omic and Regeneron Pharmaceuticals. Research Instruments: Nidek and Topcon
  • Editorial Support Disclosures, Erin K. Fletcher, MIT, director of compliance and education, Evolve; Susan Gallagher-Pecha, director of client services and project management, Evolve, have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.